Opinions

Successful partnerships between industry and academia has had a positive impact on cancer drug discovery and development in prostate cancer

Digital tools offer potential solutions to personalise the patient journey, but more effort is needed to integrate them into current healthcare settings 

Collaboration is needed to advocate for resilient healthcare systems that can navigate crises and deliver high-quality care to patients with cancer, even in the most trying circumstances 

Old and emerging traits of cancer provide a common set of principles that may help research shape future progress 

Specific training for young oncologists, particularly in managing patient expectations regarding end-of-life treatment, is paramount in providing effective, patient-centred end-of-life care 

Recently presented results suggest that a subset of patients with early stage rectal cancer could skip pre-operative radiotherapy, thus raising some questions about the standard of care

Constant advocacy by patient groups at all levels is needed to help people with cancer navigate the healthcare system ensuring access to novel medicines which is still a major issue in different countries

While increasing evidence from studies support pregnancy after cancer treatment, data gaps persist, particularly regarding the impact of novel therapies on fertility 

Recent findings regarding the role of tumour promoters in cancer development should lead to a review of the mechanisms of action of existing environmental carcinogens

Identifying the trigger that switches neutrophils from protumour to antitumour activity in the tumour microenvironment could open the door to new therapeutic options